NOVO Nordisk is on a mission to discover, develop and deliver innovative medical solutions. From its Danish headquarters, the firm has been on that path since 1923. It now employs 44,000 committed workers, with 80 international offices and a presence in 170 countries. Novo Nordisk supports the UN’s Sustainable Development Goals by providing access to affordable medicine and supporting chronic disease prevention. It applies circular economy principles to minimise environmental impact, and hopes to use renewable energy throughout its supply chain by 2030. The BV judging panel presents Novo Nordisk with the 2020 award for Best ESG Pharmaceutical Company (Scandinavia).